609
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Neisseria proteomics for antigen discovery and vaccine development

References

  • WHO. Available from: www.who.int/vaccine_research/diseases/soa_bacterial/en/index1.html
  • WHO. Global action plan to control the spread and impact of antimicrobial resistance of Neisseria gonorrhoeae. WHO; Geneva, Switzerland: 2012
  • Dull PM, McIntosh ED. Meningococcal vaccine development-from glycoconjugates against MenACWY to proteins against MenB-potential for broad protection against meningococcal disease. Vaccine 2012;30(Suppl 2):B18-25
  • Findlow H, Borrow R. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT. Adv Ther 2013;30:431-58
  • Holst J, Martin D, Arnold R, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 2009;27:B3-12
  • He Y, Rappuoli R, De Groot AS, Chen RT. Emerging vaccine informatics. J Biomed Biotechnol 2010;2010:1-26
  • Giuliani MM, du-Bobie J, Comanducci M, et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 2006;103:10834-9
  • GOV.UK. 2014. Available from: www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#publications-and-statements
  • CDC. 2014. Available from: www.cdc.gov/meningococcal/outbreaks/vaccine-serogroupB.html
  • Bernfield L, Fletcher L, Howell A, et al. Identification of a novel vaccine candidate for group B Neisseria meningitidis. Thirteenth International Pathogenic Neisseria Conference; National Institute of Public Health, Oslo, Norway; 2002. p. 116
  • Vogel U, Taha MK, Vazquez JA, et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 2013;13:416-25
  • Bettinger JA, Scheifele DW, Halperin SA, et al. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB). Vaccine 2013;32:124-30
  • Mcneil LK, Zagursky RJ, Lin SL, et al. Role of Factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev 2013;77:234-52
  • 2D protein profile of Neisseria meningitidis. 1997. Available from: http://homepages.abdn.ac.uk/p.cash/pages/neismen/neisf5_f.htm
  • Bernardini G, Renzone G, Comanducci M, et al. Proteome analysis of Neisseria meningitidis serogroup A. Proteomics 2004;4:2893-926
  • Parkhill J, Achtman M, James KD, et al. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 2000;404:502-6
  • Bernardini G, Laschi M, Serchi T, et al. Mapping phosphoproteins in Neisseria meningitidis serogroup A. Proteomics 2011;11:1351-8
  • Bernardini G, Arena S, Braconi D, et al. Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A. Proteomics 2007;7:3342-7
  • Bernardini G, Comanducci M, Bambini S, et al. Identification of new epidemiological molecular markers by comparative proteomics of serogroup A meningococcal isolates from three pandemic waves. Prot Clin Appl 2009;3:1251-4
  • Zhu P, van der Ende A, Falush D, et al. Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci USA 2001;98:5234-9
  • Mignogna G, Giorgi A, Stefanelli P, et al. Inventory of the proteins in Neisseria meningitidis serogroup B strain MC58. J Prot Res 2005;4:1361-70
  • Tettelin H, Saunders NJ, Heidelberg J, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 2000;287:1809-15
  • Tsai CM, Frasch CE, Mocca LF. Five structural classes of major outer-membrane proteins in Neisseria meningitidis. J Bact 1981;146:69-78
  • Sanchez S, Arenas J, Abel A, et al. Analysis of outer membrane protein complexes and heat-modifiable proteins in Neisseria strains using two-dimensional diagonal electrophoresis. J Prot Res 2005;4:91-5
  • Norais N, Nogarotto R, Iacobini ET, et al. Combined automated PCR cloning, in vitro transcription/translation and two-dimensional electrophoresis for bacterial proteome analysis. Proteomics 2001;1:1378-89
  • Li J, Tremblay TL, Wang C, et al. Integrated system for high-throughput protein identification using a microfabricated device coupled to capillary electrophoresis/nanoelectrospray mass spectrometry. Proteomics 2001;1:975-86
  • Post DM, Zhang D, Eastvold JS, et al. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J Biol Chem 2005;280:38383-94
  • Ferrari G, Garaguso I, Adu-Bobie J, et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 2006;6:1856-66
  • Vipond C, Suker J, Jones C, et al. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics 2006;6:3400-13
  • Tani C, Stella M, Donnarumma D, et al. Quantification by LC-MS of outer membrane vesicle proteins of the Bexsero vaccine. Vaccine 2014;32:1273-9
  • Williams JN, Skipp PJ, Humphries HE, et al. Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant. Infect Immun 2007;75:1364-72
  • van de Waterbeemd B, Mommen GP, Pennings JL, et al. Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines. J Prot Res 2013;12:1898-908
  • Hung MC, Heckels JE, Christodoulides M. The adhesin complex protein of Neisseria meningitidis is a new adhesin with vaccine potential. mBIO 2013;4:e00041-13
  • Hung MC, Heckels JE, Christodoulides M. Potential of the adhesin complex protein of Neisseria meningitidis for next-generation meningococcal vaccines. Expert Rev Vaccines 2013;12:981-4
  • Turner DPJ, Wooldridge KG, Ala’Aldeen DAA. Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein. Infect Immun 2002;70:4447-61
  • Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000;287:1816-20
  • Serruto D, Bottomley MJ, Ram S, et al. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 2012;30(Suppl 2):B87-97
  • Muzzi A, Mora M, Pizza M, et al. Conservation of meningococcal antigens in the genus Neisseria. MBio 2013;4:e00163-13
  • Tsolakos N, Lie K, Bolstad K, et al. Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media. Vaccine 2010;28:3211-18
  • Mommen GP, van de Waterbeemd B, Meiring HD, et al. Unbiased selective isolation of protein N-terminal peptides from complex proteome samples using Phospho Tagging (PTAG) and TiO2-based depletion. Mol Cell Prot 2012;11:832-42
  • Abel A, Sanchez S, Arenas J, et al. Bioinformatic analysis of outer membrane proteome of Neisseria meningitidis and Neisseria lactamica. Int Microbiol 2007;10:5-11
  • Mukhopadhyay TK, Halliwell D, O’Dwyer C, et al. Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine. Biotech Appl Biochem 2005;41:175-82
  • Vaughan TE, Skipp PJ, O’Connor CD, et al. Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine 2006;24:5277-93
  • Mendum TA, Newcombe J, McNeilly CL, McFadden J. Towards the Immunoproteome of Neisseria meningitidis. PLoS One 2009;4:e5940
  • Williams JN, Skipp PJ, O’Connor CD, et al. Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates. Infect Immun 2009;77:5080-9
  • Williams JN, Weynants V, Poolman JT, et al. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens. Vaccine 2014;32:1280-6
  • Zhang Q, Li Y, Tang CM. The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing. J Biol Chem 2010;285:34259-68
  • Newcombe J, Mendum TA, Ren CP, McFadden J. Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and MS. Microbiology 2014;160:429-38
  • Kolberg J, Hammerschmidt S, Frank R, et al. The surface-associated elongation factor Tu is concealed for antibody binding on viable pneumococci and meningococci. FEMS Immunol Med Microbiol 2008;53:222-30
  • Tsolakos N, Brookes C, Taylor S, et al. Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis. J Prot 2014;101:63-76
  • Hung MC, Salim O, Williams JN, et al. The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate. Infect Immun 2011;79:3784-91
  • Basler M, Linhartova I, Halada P, et al. The iron-regulated transcriptome and proteome of Neisseria meningitidis serogroup C. Proteomics 2006;6:6194-206
  • van Ulsen P, Kuhn K, Prinz T, et al. Identification of proteins of Neisseria meningitidis induced under iron-limiting conditions using the isobaric tandem mass tag (TMT) labeling approach. Proteomics 2009;9:1771-81
  • Byers HL, Campbell J, van Ulsen P, et al. Candidate verification of iron-regulated Neisseria meningitidis proteins using isotopic versions of tandem mass tags (TMT) and single reaction monitoring. J Prot 2009;73:231-9
  • Pannekoek Y, Huis in’t Veld R, Hopman CT, et al. Molecular characterization and identification of proteins regulated by Hfq in Neisseria meningitidis. FEMS Microbiol Lett 2009;294:216-24
  • Sun YH, Bakshi S, Chalmers R, Tang CM. Functional genomics of Neisseria meningitidis pathogenesis. Nat Med 2000;6:1269-73
  • Fantappie L, Metruccio MM, Seib KL, et al. The RNA Chaperone Hfq is involved in stress response and virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression. Infect Immun 2009;77:1842-53
  • Phillips R, Williams JN, Tan WM, et al. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis. Vaccine 2013;31:2584-90
  • Schauder S, Penna L, Ritton A, et al. Proteomics analysis by two-dimensional differential gel electrophoresis reveals the lack of a broad response of Neisseria meningitidis to in vitro-produced AI-2. J Bact 2005;187:392-5
  • Dove JE, Yasukawa K, Tinsley CR, Nassif X. Production of the signalling molecule, autoinducer-2, by Neisseria meningitidis: lack of evidence for a concerted transcriptional response. Microbiology 2003;149:1859-69
  • Hsing-Ju W, Seib K, Srikhanta Y, et al. Manganese regulation of virulence factors and oxidative stress resistance in Neisseria gonorrhoeae. J Prot 2010;73:899-916
  • Phillips NJ, Steichen CT, Schilling B, et al. Proteomic analysis of Neisseria gonorrhoeae biofilms shows shift to anaerobic respiration and changes in nutrient transport and outer membrane proteins. PLoS One 2012;7:e38303
  • Vik A, Aas FE, Anonsen JH, et al. Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc Natl Acad Sci USA 2009;106:4447-52
  • Anonsen JH, Vik A, Egge-Jacobsen W, Koomey M. An extended spectrum of target proteins and modification sites in the general O-Linked protein glycosylation system in Neisseria gonorrhoeae. J Prot Res 2012;11:5781-93
  • van Alen T, Claus H, Zahedi RP, et al. Comparative proteomic analysis of biofilm and planktonic cells of Neisseria meningitidis. Proteomics 2010;10:4512-21
  • Jagtap P, McGowan T, Bandhakavi S, et al. Deep metaproteomic analysis of human salivary supernatant. Proteomics 2012;12:992-1001
  • Pancholi V, Fischetti VA. A major surface protein on Group-A Streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding-activity. J Exp Med 1992;176:415-26
  • Brassard J, Gottschalk M, Quessy S. Cloning and purification of the Streptococcus suis serotype 2 glyceraldehyde-3-phosphate dehydrogenase and its involvement as an adhesin. Vet Microbiol 2004;102:87-94
  • Wheeler JX, Vipond C, Feavers IM. Exploring the proteome of meningococcal outer membrane vesicle vaccines. Proteomics Clin Appl 2007;1:1198-210
  • Dunning Hotopp JC, Grifantini R, Kumar N, et al. Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes. Microbiology 2006;152:3733-49
  • Pajon R, Yero D, Niebla O, et al. Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes. Vaccine 2009;28:532-41
  • Hsu CA, Lin WR, Li JC, et al. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential. Proteomics 2008;8:2115-25
  • PubMLST. 2014. Available from: http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_neisseria_isolates
  • Thelen JJ, Miernyk JA. The proteomic future: where mass spectrometry should be taking us. Biochem J 2012;444:169-81
  • Lima TB, Soares Pinto MF, Ribeiro SM, et al. Bacterial resistance mechanism: what proteomics can elucidate. Faseb J 2013;27:1291-303
  • Schmidt F, Voelker U. Proteome analysis of host-pathogen interactions: investigation of pathogen responses to the host cell environment. Proteomics 2011;11:3203-11
  • Manzano-Roman R, Dasilva N, Diez P, et al. Protein arrays as tool for studies at the host-pathogen interface. J Prot 2013;94:387-400
  • Chen B, Zhang A, Xu Z, et al. Large-Scale identification of bacteria-host crosstalk by affinity chromatography: capturing the interactions of Streptococcus suis proteins with host cells. J Prot Res 2011;10:5163-74
  • van de Waterbeemd B, Streefland M, van der Ley P, et al. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine 2010;28:4810-16
  • Grifantini R, Bartolini E, Muzzi A, et al. Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development. Ann N Y Acad Sci 2002;975:202-16
  • Schoen C, Blom J, Claus H, et al. Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci USA 2008;105:3473-8
  • Tala A, De SM, Bucci C, Alifano P. Reverse transcriptase-PCR differential display analysis of meningococcal transcripts during infection of human cells: up-regulation of priA and its role in intracellular replication. BMC Microbiol 2008;8:131
  • Takahashi H, Hirose K, Watanabe H. Necessity of meningococcal gamma-glutamyl aminopeptidase for Neisseria meningitidis growth in rat cerebrospinal fluid (CSF) and CSF-like medium. J Bact 2004;186:244-7
  • Spence JM, Tyler RE, Domaoal RA, Clark VL. L12 enhances gonococcal transcytosis of polarized Hec1B cells via the lutropin receptor. Microb Path 2002;32:117-25
  • Knaust A, Weber MV, Hammerschmidt S, et al. Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis. J Bact 2007;189:3246-55

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.